Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yuko Tanaka

Showing results (41-50 of 233) with videos related to

Pageof 24
Sort By:
Annals of Hematology|November 16, 2018
Copanlisib, a novel phosphoinositide 3-kinase inhibitor, combined with carfilzomib inhibits multiple myeloma cell proliferationSeiichi Okabe, Yuko Tanaka, Tetsuzo Tauchi, et al.
Internal Medicine (Tokyo, Japan)|October 3, 2009
Factors influencing pre-hospital delay after ischemic stroke and transient ischemic attackYuko Tanaka, Makoto Nakajima, Teruyuki Hirano, et al.
Journal of Hematology & Oncology|August 3, 2011
Dasatinib preferentially induces apoptosis by inhibiting Lyn kinase in nilotinib-resistant chronic myeloid leukemia cell lineSeiichi Okabe, Tetsuzo Tauchi, Yuko Tanaka, et al.
Archives of Virology|February 19, 2022
Genomic characterization of a fowl adenovirus serotype 4 strain isolated from a chicken with hydropericardium syndrome in JapanMasaji Mase, Yuko Tanaka, Hiroshi Iseki, et al.
Oncotarget|September 11, 2018
Therapeutic targeting of Aurora A kinase in Philadelphia chromosome-positive ABL tyrosine kinase inhibitor-resistant cellsSeiichi Okabe, Tetsuzo Tauchi, Yuko Tanaka, et al.
Oncology Letters|March 7, 2022
Potential of a sphingosine 1-phosphate receptor antagonist and sphingosine kinase inhibitors as targets for multiple myeloma treatmentYuko Tanaka, Seiichi Okabe, Kazuma Ohyashiki, et al.
Surgical Neurology International|July 14, 2025
Visual symptoms after flow-diverter stenting of internal carotid artery aneurysms: A retrospective cohort studyYuko Tanaka, Yoshikazu Matsuda, Tomoyuki Tsumoto, et al.
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|December 14, 2025
Vaccine-related beliefs and preventive behavior among Japanese travelers staying at a budget guesthouse in New Delhi, India: travel vaccinations after the COVID-19 pandemicMichiyo Yamakawa, Yuko Tanaka, Akiko Tokinobu, et al.
International Cancer Conference Journal|October 14, 2024
Effectiveness of trastuzumab deruxtecan rechallenge in a patient with HER2-positive metastatic breast cancer: a case reportYuko Tanaka, Naoya Ikeda, Seiji Niho, et al.
Cancer Cell International|June 27, 2023
WEE1 and PARP-1 play critical roles in myelodysplastic syndrome and acute myeloid leukemia treatmentSeiichi Okabe, Yuko Tanaka, Mitsuru Moriyama, et al.
Pageof 24

Showing results (41-50 of 233) with videos related to

Sort By:
Pageof 24
Annals of Hematology|November 16, 2018
Copanlisib, a novel phosphoinositide 3-kinase inhibitor, combined with carfilzomib inhibits multiple myeloma cell proliferationSeiichi Okabe, Yuko Tanaka, Tetsuzo Tauchi, et al.
Internal Medicine (Tokyo, Japan)|October 3, 2009
Factors influencing pre-hospital delay after ischemic stroke and transient ischemic attackYuko Tanaka, Makoto Nakajima, Teruyuki Hirano, et al.
Journal of Hematology & Oncology|August 3, 2011
Dasatinib preferentially induces apoptosis by inhibiting Lyn kinase in nilotinib-resistant chronic myeloid leukemia cell lineSeiichi Okabe, Tetsuzo Tauchi, Yuko Tanaka, et al.
Archives of Virology|February 19, 2022
Genomic characterization of a fowl adenovirus serotype 4 strain isolated from a chicken with hydropericardium syndrome in JapanMasaji Mase, Yuko Tanaka, Hiroshi Iseki, et al.
Oncotarget|September 11, 2018
Therapeutic targeting of Aurora A kinase in Philadelphia chromosome-positive ABL tyrosine kinase inhibitor-resistant cellsSeiichi Okabe, Tetsuzo Tauchi, Yuko Tanaka, et al.
Oncology Letters|March 7, 2022
Potential of a sphingosine 1-phosphate receptor antagonist and sphingosine kinase inhibitors as targets for multiple myeloma treatmentYuko Tanaka, Seiichi Okabe, Kazuma Ohyashiki, et al.
Surgical Neurology International|July 14, 2025
Visual symptoms after flow-diverter stenting of internal carotid artery aneurysms: A retrospective cohort studyYuko Tanaka, Yoshikazu Matsuda, Tomoyuki Tsumoto, et al.
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|December 14, 2025
Vaccine-related beliefs and preventive behavior among Japanese travelers staying at a budget guesthouse in New Delhi, India: travel vaccinations after the COVID-19 pandemicMichiyo Yamakawa, Yuko Tanaka, Akiko Tokinobu, et al.
International Cancer Conference Journal|October 14, 2024
Effectiveness of trastuzumab deruxtecan rechallenge in a patient with HER2-positive metastatic breast cancer: a case reportYuko Tanaka, Naoya Ikeda, Seiji Niho, et al.
Cancer Cell International|June 27, 2023
WEE1 and PARP-1 play critical roles in myelodysplastic syndrome and acute myeloid leukemia treatmentSeiichi Okabe, Yuko Tanaka, Mitsuru Moriyama, et al.
Pageof 24